Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 26 results found. Search for [ Mankind Pharma ]

Results 1 to 21 of 26
PTI
March 6, 2019



PTI
January 9, 2019



PTI
January 9, 2019



PTI
January 7, 2019



PTI
January 7, 2019



PB Jayakumar
New Delhi, January 16, 2018
Pegged at over Rs 18,862 crore by a Nicholas Hall 2017 report, the Indian OTC market is expected to grow at a compounded annual growth rate (CAGR) of 9 percent to cross Rs 44,115 crore.


PB Jayakumar
New Delhi, December 5, 2017
The OTC business of Piramal, already among the top five OTC specialists in the Rs 20,000 crore market, had revenues of Rs 375 crore in 2016-17, a jump of 44 per cent compared to the Rs 261 crore it posted in the previous year.


E. Kumar Sharma
New Delhi, November 25, 2017
Pharma stocks continue to underperform as policy uncertainty adds to the toll taken by USFDA and market challenges.


Sonal Khetarpal
New Delhi, October 30, 2017
Patanjali has major a drastic move up from 87th to 12th position this year. Google that has climbed to 19 position, a sharp rise from 102 rank last year.


BT Online
September 26, 2017
Balkrishna owns close to 94 per cent of Patanjali Ayurved and is the brain behind the admirable growth of Patanjali as a consumer brand. Patanjali has secured a second place in Indian FMCG market share in under 5 years.


PTI
New Delhi, September 25, 2017
Ambani retains the richest Indian title for the sixth year running and this year he has climbed to top 15 in the Hurun global rich list for the first time. His wealth is 50 per cent more than GDP of Yemen, the country of his birth.


BT Online
August 4, 2017
This is how Twitter reacted after Manforce announced 'Achari' condoms.


P. B. Jayakumar
Delhi, May 1, 2017
Arjun Juneja joined New Delhi-based Mankind Pharma in 2008 after completing his Bachelor of Business Management from the University of Bradford and MBA from the University of Strathclyde, UK.


Rajeev Dubey
Delhi, May 1, 2017
A group of inheritors takes charge with new ideas and new strategies


By E. Kumar Sharma
Delhi, April 25, 2016
In the third quarter, Dr. Reddy's revenues from India rose 34 per cent from the corresponding quarter of the previous year (partly due to acquisition of a few established brands of Belgian company UCB in India). However, in March, the growth was 7 per cent.


Zeba Siddiqui
New Delhi, March 7, 2016
Dinesh Thakur, who exposed dangerous practices in generic drug industry in 2013, is accusing the drug regulators of failing to enforce safety rules in the $15 billion industry.


PTI
Mumbai, October 15, 2015
\"We have invested Rs 150 crore in our plant in Paonta Sahib and are expecting to launch 35 products by the end 2016,\" Mankind Pharma MD Sheetal Arora said in a statement.


PB Jayakumar
October 13, 2015
Basudeo Singh, Executive Chairman, said the IPO is to create visibility for the company for future growth and help some relatives and friends of the promoters monetise riches of the 43-year-old company.


P.B. Jayakumar, E. Kumar Sharma and Venkatesha Babu
June 17, 2015
Most of them started with very little capital and resources. And all of them persevered through the bad times of the industry.


Zeba Siddiqui
Mumbai, April 10, 2015
Mankind Pharmaceuticals is also exploring buying established brands to expand its domestic footprint, Managing Director Sheetal Arora said.


PAGES 1 OF 2  12